NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

全球醫用大麻市場:行業趨勢和預測(至 2028 年)

Global Medical Cannabis Market - Industry Trends and Forecast to 2028

出版商 Data Bridge Market Research Private Limited 商品編碼 1004441
出版日期 內容資訊 英文 749 Pages
商品交期: 最快1-2個工作天內
價格
全球醫用大麻市場:行業趨勢和預測(至 2028 年) Global Medical Cannabis Market - Industry Trends and Forecast to 2028
出版日期: 2021年03月01日內容資訊: 英文 749 Pages
簡介

從 2021 年到 2028 年,全球醫用大麻市場預計將以 25.16% 的複合年增長率增長。吸毒增加、大麻合法化、製造商對醫用大麻的努力、大麻種子的化妝品應用、大麻的功能特性和工業應用是推動該市場增長的因素。

本報告調查了全球醫用大麻市場,包括市場概況、產品/用途/提取物/原料/種類/給藥途徑/最終用戶/分銷渠道/區域市場趨勢,以及新型冠狀病毒感染(它提供了影響等綜合信息) COVID-19)、主要地區的市場份額、SWOT 分析、競爭形勢以及主要公司的概況。

目錄

第 1 章介紹

第 2 章市場細分

第 3 章執行摘要

第 4 章重要考慮事項

各國的第 5 章規定

  • 美國
  • 加拿大
  • 澳大利亞
  • 泰國

第6章供應鏈分析

  • 農民/種植者
  • 製作人
  • 檢查員
  • 批發商/分銷商
  • 零售商

第 7 章市場概覽

  • 促進因素
    • 藥物使用增加
    • 大麻合法化
    • 廠商的努力
    • 大麻籽在化妝品中的使用增加
    • 大麻的功能特性和工業用途的增加
  • 抑製器
    • 大麻使用的複雜監管結構
    • 長期使用可能產生不良反應
    • 成本高
  • 市場機會
    • 研發活動增加導致的新產品開發
    • 越來越多地將大麻用於娛樂目的
    • 老年人口越來越多
    • 慢性病患病率增加
  • 挑戰
    • 大麻黑市的興起
    • 與使用大麻相關的副作用
    • 人手不足

第 8 章冠狀病毒傳染病 (COVID-19) 的影響

  • 對價格的影響
  • 對需求的影響
  • 對供應的影響
  • 漩渦中的 COVID-19 企業計劃
  • 結論

第 9 章全球醫用大麻市場:按產品

  • 概述
  • 醫用乾大麻
  • 醫用大麻膠囊
  • 筆狀蒸氣
  • 全花耳朵
  • 保濕霜
  • 粗粒尖刺
  • 補丁
  • 面膜精華
  • 潔面乳
  • 其他

第 10 章全球醫用大麻市場:按用途

  • 概述
  • 疼痛管理
  • 抗焦慮
  • 肌肉痙攣
  • 噁心
  • 食慾不振
  • 癌症
  • 關節炎
  • 阿爾茨海默病/偏頭痛
  • 癲癇
  • 抑鬱症/睡眠障礙
  • 多發性硬化症
  • 自閉症
  • 精神疾病
  • 振奮人心
  • 其他

第 11 章全球醫用大麻市場:按提取物

  • 概述
  • 大麻二酚 (CBD)
  • 四氫大麻酚 (THC)/DELTA-8-四氫大麻酚
  • 補丁
  • 大麻酚 (CBG)
  • 大麻酚 (CBN)
  • 其他

第 12 章全球醫用大麻市場:按原材料

  • 概述
  • 天然原料
  • 複合

第 13 章全球醫用大麻市場:按類型

  • 概述
  • 苜蓿
  • 混合
  • 秈稻

第 14 章全球醫用大麻市場:按給藥途徑

  • 概述
  • 口服(液體/膠囊)
  • 吸煙
  • 本地
  • 汽化
  • 其他

第 15 章全球醫用大麻市場:按最終用戶

  • 概述
  • 家庭醫療
  • 醫院
  • 康復中心
  • 製藥
  • 研發機構
  • 其他

第 16 章全球醫用大麻市場:按分銷渠道

  • 概述
  • B2C
    • 藥房
    • 傳統商店
    • 網上商店
    • 其他
  • B2B

第 17 章全球醫用大麻市場:按地區

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 意大利
    • 英國
    • 荷蘭
    • 瑞士
    • 法國
    • 俄羅斯
    • 西班牙
    • 比利時
    • 其他
  • 亞太地區
    • 澳大利亞
    • 泰國
    • 韓國
    • 日本
    • 中國
    • 新加坡
    • 印度
    • 馬來西亞
    • 菲律賓
    • 其他
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他
  • 中東/非洲
    • 以色列
    • 南非
    • 其他

第 18 章全球醫用大麻市場:企業狀況

  • 公司股票分析:世界
  • 公司份額分析:北美
  • 公司份額分析:歐洲
  • 企業股票分析:亞太地區

第19章SWOT分析

第20章公司簡介

  • MEDIPHARM LABS INC.
  • APHRIA INC.
  • TILRAY
  • ZENABIS GLOBAL LTD.
  • AURORA CANNABIS
  • GW PHARMACEUTICALS PLC
  • ALTHEA COMPANY PTY LTD(A SUBSIDIARY OF ALTHEA GROUP)
  • APOTHECANNA
  • BARNEY'S FARM
  • BIOACTIVE SOLUTIONS, INC.
  • BOL PHARMA
  • CANNABIS SEEDS USA
  • CANOPY GROWTH CORPORATION
  • CRESCO LABS
  • CROP KING SEEDS
  • DISCOVER HEALTH LLC
  • ECOGEN BIOSCIENCES
  • ELIXINOL GLOBAL LIMITED
  • ENDOCA
  • EXTRACTAS
  • FOLIUM BIOSCIENCES
  • GREENWICH BIOSCIENCES, INC.
  • HARMONY
  • HUMBOLDT SEED COMPANY
  • IDT AUSTRALIA
  • KIEHL'S(A SUBSIDIARY OF L'OREAL)
  • MARY'S NUTRITIONALS, LLC
  • MEDICAL MARIJUANA, INC.
  • MEDIFARM
  • PACIFIC ROOTS
  • PHARMAHEMP
  • PURE RATIOS
  • PEACE NATURALS PROJECT INC.
  • SEED CELLAR
  • SEEDS FOR ME
  • THC GLOBAL GROUP LIMITED
  • UPSTATE ELEVATOR SUPPLY CO.
  • VERMONT HEMP HEALTH

第 21 章問卷

第22章相關報導

目錄

Global medical cannabis market is projected to register a CAGR of 25.16% in the forecast period of 2021 to 2028. The new market report contains data for the historic year 2019, the base year of calculation is 2020 and the forecast period is 2021 to 2028.

Market Segmentation:

Global Medical Cannabis Market, By Product (Oil, Dried Medical Cannabis, Medical Cannabis Capsules, Vape Pen, Whole Flower, Creams & Moisturizer, Ground Flower, Patch, Mask & Serum, Cleanser, Others), Source (Natural, Synthetic), Species (Sativa, Hybrid, Cannabis Indica), Derivatives (Cannabidiol (CBD), Tetrahydrocannabinol (THC)/Delta-8-Tetrahydrocannabinol, Cannabigerol (CBG), Cannabinol, Others), Application (Pain Management, Anxiety, Muscle Spasms, Nausea, Appetite Loss, Cancer, Arthritis, Alzheimer's Disease, Epilepsy, Depression and Sleep Disorders, Multiple Sclerosis, Autism, Mental Health Conditions, Elevate Mood, Others), Route of Administration (Oral Solutions and Capsules, Smoking, Topicals, Vaporizers, Others), End User (Homecare Settings, Hospital and Rehab Centers, Pharmaceutical Industry, Research and Development Centers, Others), Distribution Channel (B2C, B2B), Country (U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Russia, Netherlands, Switzerland, Belgium, Turkey & Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific , Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028

Some of the major factors contributing to the growth of Europe medical cannabis market are:

Escalation in healthcare expenditure

Functional properties of cannabis and their increased use in different industries

Market Players:

The key market players for global medical cannabis market are listed below:

Tilray

Elixinol Global Limited

Medical Marijuana, Inc.

Extractas

Peace Naturals Project Inc.

BOL Pharma

PharmaHemp

Kiehl's (A Subsidiary of L'OREAL)

Vermont Hemp Health

Discover Health LLC

ENDOCA,

Pacific roots

CANOPY GROWTH CORPORATION

Aurora Cannabis

GW Pharmaceuticals plc.

Harmony

Pure Ratios

MARY's nutritionals

Bioactive Solutions, Inc.

Upstate Elevator Supply Co.

FOLIUM BIOSCIENCES

EcoGen Biosciences

Althea Company Pty Ltd (A Subsidiary of Althea Group Holdings Limited)

Apothecanna

Zenabis Global Ltd

Cresco Labs, IDT Australia

MEDIFARM

Greenwich Biosciences, Inc.

MediPharm Labs Inc.

THC Global Group Limited

Seed Cellar

CANNABIS SEEDS USA,

Seeds For Me

HUMBOLDT SEED COMPANY

Crop King Seeds

BARNEY'S FARM

Aphria Inc.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 OVERVIEW OF GLOBAL MEDICAL CANNABIS MARKET
  • 1.4 LIMITATIONS
  • 1.5 MARKETS COVERED

2 MARKET SEGMENTATION

  • 2.1 MARKETS COVERED
  • 2.2 GEOGRAPHICAL SCOPE
  • 2.3 YEARS CONSIDERED FOR THE STUDY
  • 2.4 CURRENCY AND PRICING
  • 2.5 DBMR TRIPOD DATA VALIDATION MODEL
  • 2.6 MULTIVARIATE MODELLING
  • 2.7 PRODUCT LIFELINE CURVE
  • 2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
  • 2.9 DBMR MARKET POSITION GRID
  • 2.10 MARKET APPLICATION COVERAGE GRID
  • 2.11 VENDOR SHARE ANALYSIS
  • 2.12 SECONDARY SOURCES
  • 2.13 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 GLOBAL MEDICAL CANNABIS MARKET: REGULATIONS

  • 5.1 UNITED STATES
  • 5.2 CANADA
  • 5.3 AUSTRALIA
  • 5.4 THAILAND

6 GLOBAL MEDICAL CANNABIS MARKET: SUPPLY CHAIN ANALYSIS

  • 6.1 CULTIVATORS AND GROWERS
  • 6.2 MANUFACTURER AND PRODUCER
  • 6.3 TESTERS
  • 6.4 WHOLESALE AND DISTRIBUTORS
  • 6.5 RETAILERS

7 MARKET OVERVIEW

  • 7.1 DRIVERS
    • 7.1.1 INCREASED MEDICINAL USE
    • 7.1.2 LEGALIZATION OF CANNABIS
    • 7.1.3 INITIATIVES TAKEN BY MANUFACTURERS
    • 7.1.4 INCREASED USAGE OF CANNABIS SEEDS IN COSMETIC PRODUCTS
    • 7.1.5 FUNCTIONAL PROPERTIES OF CANNABIS AND THEIR INCREASED USE IN DIFFERENT INDUSTRIES
  • 7.2 RESTRAINTS
    • 7.2.1 COMPLEX REGULATORY STRUCTURE FOR USAGE OF CANNABIS
    • 7.2.2 LONG TERM USE CAN CAUSE ADVERSE EFFECTS
    • 7.2.3 HIGH COST
  • 7.3 OPPORTUNITIES
    • 7.3.1 NOVEL PRODUCT DEVELOPMENT WITH INCREASING R & D ACTIVITIES
    • 7.3.2 INCREASED ADOPTION OF CANNABIS FOR RECREATIONAL PURPOSE
    • 7.3.3 GROWING GERIATRIC POPULATION
    • 7.3.4 INCREASING PREVALENCE OF CHRONIC DISEASES
  • 7.4 CHALLENGES
    • 7.4.1 RISE OF MARIJUANA BLACK MARKET
    • 7.4.2 SIDE EFFECTS RELATED TO THE USE OF CANNABIS
    • 7.4.3 SHORTAGE OF PERSONNEL

8 IMPACT OF COVID-19 ON GLOBAL MEDICAL CANNABIS MARKET

  • 8.1 IMPACT ON PRICE
  • 8.2 IMPACT ON DEMAND
  • 8.3 IMPACT ON SUPPLY
  • 8.4 KEY INITIATIVES BY MARKET PLAYER DURING COVID 19

8.5 CONCLUSION:

9 GLOBAL MEDICAL CANNABIS MARKET, BY PRODUCT

  • 9.1 OVERVIEW
  • 9.2 OIL
    • 9.2.1 BY TYPE
      • 9.2.1.1 CBD Oil Concentrates
      • 9.2.1.2 CBD Vape Oil
      • 9.2.1.3 CBD Tinctures
    • 9.2.2 BY SOURCE
      • 9.2.2.1 Marijuana Based
      • 9.2.2.2 Hemp Based
    • 9.2.3 BY SPECIES
      • 9.2.3.1 Sativa
      • 9.2.3.2 Hybrid
      • 9.2.3.3 Cannabis Indica
  • 9.3 DRIED MEDICAL CANNABIS
    • 9.3.1 CANNABIS INDICA
    • 9.3.2 SATIVA
    • 9.3.3 HYBRID
  • 9.4 MEDICAL CANNABIS CAPSULES
    • 9.4.1 BY TYPE
      • 9.4.1.1 Oil Based Cannabis Capsules
      • 9.4.1.2 Power Based Cannabis Capsules
      • 9.4.1.3 Others
    • 9.4.2 BY CONCENTRATES
      • 9.4.2.1 High CBD Capsules Digital
      • 9.4.2.2 High THC Capsule
      • 9.4.2.3 THC/CBD balanced capsule
      • 9.4.2.4 CBD Isolate Capsule
      • 9.4.2.5 By Species
      • 9.4.2.6 Sativa
      • 9.4.2.7 Hybrid
      • 9.4.2.8 Cannabis Indica
  • 9.5 VAPE PEN
    • 9.5.1 CANNABIS INDICA
    • 9.5.2 SATIVA
    • 9.5.3 HYBRID
  • 9.6 WHOLE FLOWER
    • 9.6.1 SATIVA
    • 9.6.2 HYBRID
    • 9.6.3 CANNABIS INDICA
  • 9.7 CREAMS & MOISTURIZER
  • 9.8 GROUND FLOWER
    • 9.8.1 SATIVA
    • 9.8.2 CANNABIS INDICA
    • 9.8.3 HYBRID
  • 9.9 PATCH
  • 9.10 MASK & SERUM
  • 9.11 CLEANSER
  • 9.12 OTHERS

10 GLOBAL MEDICAL CANNABIS MARKET, BY APPLICATION

  • 10.1 OVERVIEW
  • 10.2 PAIN MANAGEMENT
    • 10.2.1 OIL
    • 10.2.2 MEDICAL CANNABIS AND CAPSULES
    • 10.2.3 DRIED MEDICAL CANNABIS
    • 10.2.4 PATCH
    • 10.2.5 GROUND FLOWER
    • 10.2.6 CREAMS & MOISTURIZER
    • 10.2.7 VAPE PEN
    • 10.2.8 WHOLE FLOWER
    • 10.2.9 MASKS & SERUM
    • 10.2.10 CLEANSER
    • 10.2.11 OTHERS
  • 10.3 ANXIETY
    • 10.3.1 OIL
    • 10.3.2 DRIED MEDICAL CANNABIS
    • 10.3.3 MEDICAL CANNABIS AND CAPSULES
    • 10.3.4 GROUND FLOWER
    • 10.3.5 VAPE PEN
    • 10.3.6 WHOLE FLOWER
    • 10.3.7 OTHERS
  • 10.4 MUSCLE SPASMS
    • 10.4.1 OIL
    • 10.4.2 MEDICAL CANNABIS AND CAPSULES
    • 10.4.3 DRIED MEDICAL CANNABIS
    • 10.4.4 PATCH
    • 10.4.5 CREAMS & MOISTURIZER
    • 10.4.6 GROUND FLOWER
    • 10.4.7 VAPE PEN
    • 10.4.8 WHOLE FLOWER
    • 10.4.9 MASKS & SERUM
    • 10.4.10 CLEANSER
    • 10.4.11 OTHERS
  • 10.5 NAUSEA
    • 10.5.1 OIL
    • 10.5.2 MEDICAL CANNABIS AND CAPSULES
    • 10.5.3 DRIED MEDICAL CANNABIS
    • 10.5.4 GROUND FLOWER
    • 10.5.5 CREAMS & MOISTURIZER
    • 10.5.6 PATCH
    • 10.5.7 VAPE PEN
    • 10.5.8 WHOLE FLOWER
    • 10.5.9 MASKS & SERUM
    • 10.5.10 CLEANSER
    • 10.5.11 OTHERS
  • 10.6 APPETITE LOSS
    • 10.6.1 OIL
    • 10.6.2 MEDICAL CANNABIS AND CAPSULES
    • 10.6.3 DRIED MEDICAL CANNABIS
    • 10.6.4 GROUND FLOWER
    • 10.6.5 WHOLE FLOWER
    • 10.6.6 VAPE PEN
    • 10.6.7 PATCH
    • 10.6.8 OTHERS
  • 10.7 CANCER
    • 10.7.1 OIL
    • 10.7.2 MEDICAL CANNABIS AND CAPSULES
    • 10.7.3 DRIED MEDICAL CANNABIS
    • 10.7.4 PATCH
    • 10.7.5 GROUND FLOWER
    • 10.7.6 VAPE PEN
    • 10.7.7 WHOLE FLOWER
    • 10.7.8 OTHERS
  • 10.8 ARTHRITIS
    • 10.8.1 OIL
    • 10.8.2 MEDICAL CANNABIS AND CAPSULES
    • 10.8.3 DRIED MEDICAL CANNABIS
    • 10.8.4 PATCH
    • 10.8.5 GROUND FLOWER
    • 10.8.6 CREAMS & MOISTURIZER
    • 10.8.7 MASKS & SERUM
    • 10.8.8 WHOLE FLOWER
    • 10.8.9 VAPE PEN
    • 10.8.10 CLEANSER
    • 10.8.11 OTHERS
  • 10.9 ALZHEIMER'S DISEASE/MIGRANES
    • 10.9.1 OIL
    • 10.9.2 DRIED MEDICAL CANNABIS
    • 10.9.3 MEDICAL CANNABIS AND CAPSULES
    • 10.9.4 PATCH
    • 10.9.5 GROUND FLOWER
    • 10.9.6 VAPE PEN
    • 10.9.7 WHOLE FLOWER
    • 10.9.8 OTHERS
  • 10.10 EPILEPSY
    • 10.10.1 OIL
    • 10.10.2 MEDICAL CANNABIS AND CAPSULES
    • 10.10.3 OTHERS
  • 10.11 DEPRESSION AND SLEEP DISORDERS
    • 10.11.1 OIL
    • 10.11.2 DRIED MEDICAL CANNABIS
    • 10.11.3 MEDICAL CANNABIS AND CAPSULES
    • 10.11.4 PATCH
    • 10.11.5 CREAMS & MOISTURIZER
    • 10.11.6 OTHERS
  • 10.12 MULTIPLE SCLEROSIS
    • 10.12.1 OIL
    • 10.12.2 DRIED MEDICAL CANNABIS
    • 10.12.3 MEDICAL CANNABIS AND CAPSULES
    • 10.12.4 PATCH
    • 10.12.5 GROUND FLOWER
    • 10.12.6 VAPE PEN
    • 10.12.7 WHOLE FLOWER
    • 10.12.8 OTHERS
  • 10.13 AUTISM
    • 10.13.1 OIL
    • 10.13.2 MEDICAL CANNABIS AND CAPSULES
    • 10.13.3 OTHERS
  • 10.14 MENTAL HEALTH CONDITIONS
    • 10.14.1 OIL
    • 10.14.2 MEDICAL CANNABIS AND CAPSULES
    • 10.14.3 OTHERS
  • 10.15 ELEVATE MOOD
    • 10.15.1 OIL
    • 10.15.2 DRIED MEDICAL CANNABIS
    • 10.15.3 MEDICAL CANNABIS AND CAPSULES
    • 10.15.4 PATCH
    • 10.15.5 CREAMS & MOISTURIZER
    • 10.15.6 MASKS & SERUM
    • 10.15.7 CLEANSER
    • 10.15.8 OTHERS
  • 10.16 OTHERS

11 GLOBAL MEDICAL CANNABIS MARKET, BY DERIVATIVES

  • 11.1 OVERVIEW
  • 11.2 CANNABIDIOL (CBD)
    • 11.2.1 OIL
    • 11.2.2 MEDICAL CANNABIS CAPSULES
    • 11.2.3 GROUND FLOWER
    • 11.2.4 PATCH
    • 11.2.5 CREAMS & MOISTURIZER
    • 11.2.6 VAPE PEN
    • 11.2.7 WHOLE FLOWER
    • 11.2.8 MASKS & SERUM
    • 11.2.9 CLEANSER
    • 11.2.10 OTHERS
  • 11.3 TETRAHYDROCANNABINOL (THC)/DELTA-8-TETRAHYDROCANNABINOL
    • 11.3.1 OIL
    • 11.3.2 MEDICAL CANNABIS CAPSULES
    • 11.3.3 DRIED MEDICAL CANNABIS
    • 11.3.4 GROUND FLOWER
  • 11.4 PATCH
    • 11.4.1 CREAMS & MOISTURIZER
    • 11.4.2 WHOLE FLOWER
    • 11.4.3 VAPE PEN
    • 11.4.4 MASKS & SERUM
    • 11.4.5 CLEANSER
    • 11.4.6 OTHERS
  • 11.5 CANNABIGEROL (CBG)
    • 11.5.1 OIL
    • 11.5.2 WHOLE FLOWER
    • 11.5.3 MEDICAL CANNABIS AND CAPSULES
    • 11.5.4 CLEANSER
  • 11.6 CANNABINOL (CBN)
  • 11.7 OTHERS

12 GLOBAL MEDICAL CANNABIS MARKET, BY SOURCE

  • 12.1 OVERVIEW
  • 12.2 NATURAL
  • 12.3 SYNTHETIC

13 GLOBAL MEDICAL CANNABIS MARKET, BY SPECIES

  • 13.1 OVERVIEW
  • 13.2 SATIVA
  • 13.3 HYBRID
  • 13.4 CANNABIS INDICA

14 GLOBAL MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION

  • 14.1 OVERVIEW
  • 14.2 ORAL SOLUTIONS AND CAPSULES
  • 14.3 SMOKING
  • 14.4 TOPICALS
  • 14.5 VAPORIZERS
  • 14.6 OTHERS

15 GLOBAL MEDICAL CANNABIS MARKET, BY END USER

  • 15.1 OVERVIEW
  • 15.2 HOMECARE SETTING
  • 15.3 HOSPITAL
  • 15.4 REHAB CENTERS
  • 15.5 PHARMACEUTICAL INDUSTRY
  • 15.6 RESEARCH AND DEVELOPMENT CENTERS
  • 15.7 OTHERS

16 GLOBAL MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL

  • 16.1 OVERVIEW
  • 16.2 B2C
    • 16.2.1 PHARMACIES
    • 16.2.2 CONVENTIONAL STORES
    • 16.2.3 ONLINE STORES
    • 16.2.4 OTHERS
  • 16.3 B2B

17 GLOBAL MEDICAL CANNABIS MARKET BY GEOGRAPHY

  • 17.1 NORTH AMERICA
    • 17.1.1 U.S.
    • 17.1.2 CANADA
    • 17.1.3 MEXICO
  • 17.2 EUROPE
    • 17.2.1 GERMANY
    • 17.2.2 ITALY
    • 17.2.3 U.K.
    • 17.2.4 NETHERLANDS
    • 17.2.5 SWITZERLAND
    • 17.2.6 FRANCE
    • 17.2.7 RUSSIA
    • 17.2.8 SPAIN
    • 17.2.9 BELGIUM
    • 17.2.10 REST OF EUROPE
  • 17.3 ASIA-PACIFIC
    • 17.3.1 AUSTRALIA
    • 17.3.2 THAILAND
    • 17.3.3 SOUTH KOREA
    • 17.3.4 JAPAN
    • 17.3.5 CHINA
    • 17.3.6 SINGAPORE
    • 17.3.7 INDIA
    • 17.3.8 MALAYSIA
    • 17.3.9 PHILIPPINES
    • 17.3.10 REST OF ASIA-PACIFIC
  • 17.4 SOUTH AMERICA
    • 17.4.1 BRAZIL
    • 17.4.2 ARGENTINA
    • 17.4.3 REST OF SOUTH AMERICA
  • 17.5 MIDDLE EAST AND AFRICA
    • 17.5.1 ISRAEL
    • 17.5.2 SOUTH AFRICA
    • 17.5.3 REST OF MIDDLE EAST AND AFRICA

18 GLOBAL MEDICAL CANNABIS MARKET: COMPANY LANDSCAPE

  • 18.1 COMPANY SHARE ANALYSIS: GLOBAL
  • 18.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
  • 18.3 COMPANY SHARE ANALYSIS: EUROPE
  • 18.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC

19 SWOT ANALYSIS

20 COMPANY PROFILE

  • 20.1 MEDIPHARM LABS INC.
    • 20.1.1 COMPANY SNAPSHOT
    • 20.1.2 REVENUE ANALYSIS
    • 20.1.3 COMPANY SHARE ANALYSIS
    • 20.1.4 PRODUCT PORTFOLIO
    • 20.1.5 RECENT DEVELOPMENTS
  • 20.2 APHRIA INC.
    • 20.2.1 COMPANY SNAPSHOT
    • 20.2.2 REVENUE ANALYSIS
    • 20.2.3 COMPANY SHARE ANALYSIS
    • 20.2.4 PRODUCT PORTFOLIO
    • 20.2.5 RECENT DEVELOPMENTS
  • 20.3 TILRAY
    • 20.3.1 COMPANY SNAPSHOT
    • 20.3.2 COMPANY SHARE ANALYSIS
    • 20.3.3 PRODUCT PORTFOLIO
    • 20.3.4 RECENT DEVELOPMENTS
  • 20.4 ZENABIS GLOBAL LTD.
    • 20.4.1 COMPANY SNAPSHOT
    • 20.4.2 REVENUE ANALYSIS
    • 20.4.3 COMPANY SHARE ANALYSIS
    • 20.4.4 PRODUCT PORTFOLIO
    • 20.4.5 RECENT DEVELOPMENTS
  • 20.5 AURORA CANNABIS
    • 20.5.1 COMPANY SNAPSHOT
    • 20.5.2 REVENUE ANALYSIS
    • 20.5.3 COMPANY SHARE ANALYSIS
    • 20.5.4 PRODUCT PORTFOLIO
    • 20.5.5 RECENT DEVELOPMENTS
  • 20.6 GW PHARMACEUTICALS PLC
    • 20.6.1 COMPANY SNAPSHOT
    • 20.6.2 REVENUE ANALYSIS
    • 20.6.3 PRODUCT PORTFOLIO
    • 20.6.4 RECENT DEVELOPMENTS
  • 20.7 ALTHEA COMPANY PTY LTD (A SUBSIDIARY OF ALTHEA GROUP)
    • 20.7.1 COMPANY SNAPSHOT
    • 20.7.2 REVENUE ANALYSIS
    • 20.7.3 PRODUCT PORTFOLIO
    • 20.7.4 RECENT DEVELOPMENTS
  • 20.8 APOTHECANNA
    • 20.8.1 COMPANY SNAPSHOT
    • 20.8.2 PRODUCT PORTFOLIO
    • 20.8.3 RECENT DEVELOPMENT
  • 20.9 BARNEY'S FARM
    • 20.9.1 COMPANY SNAPSHOT
    • 20.9.2 PRODUCT PORTFOLIO
    • 20.9.3 RECENT DEVELOPMENTS
  • 20.10 BIOACTIVE SOLUTIONS, INC.
    • 20.10.1 COMPANY SNAPSHOT
    • 20.10.2 PRODUCT PORTFOLIO
    • 20.10.3 RECENT DEVELOPMENT
  • 20.11 BOL PHARMA
    • 20.11.1 COMPANY SNAPSHOT
    • 20.11.2 PRODUCT PORTFOLIO
    • 20.11.3 RECENT DEVELOPMENTS
  • 20.12 CANNABIS SEEDS USA
    • 20.12.1 COMPANY SNAPSHOT
    • 20.12.2 PRODUCT PORTFOLIO
    • 20.12.3 RECENT DEVELOPMENT
  • 20.13 CANOPY GROWTH CORPORATION
    • 20.13.1 COMPANY SNAPSHOT
    • 20.13.2 REVENUE ANALYSIS
    • 20.13.3 PRODUCT PORTFOLIO
    • 20.13.4 RECENT DEVELOPMENTS
  • 20.14 CRESCO LABS
    • 20.14.1 COMPANY SNAPSHOT
    • 20.14.2 PRODUCT PORTFOLIO
    • 20.14.3 RECENT DEVELOPMENTS
  • 20.15 CROP KING SEEDS
    • 20.15.1 COMPANY SNAPSHOT
    • 20.15.2 PRODUCT PORTFOLIO
    • 20.15.3 RECENT DEVELOPMENT
  • 20.16 DISCOVER HEALTH LLC
    • 20.16.1 COMPANY SNAPSHOT
    • 20.16.2 PRODUCT PORTFOLIO
    • 20.16.3 RECENT DEVELOPMENTS
  • 20.17 ECOGEN BIOSCIENCES
    • 20.17.1 COMPANY SNAPSHOT
    • 20.17.2 PRODUCT PORTFOLIO
    • 20.17.3 RECENT DEVELOPMENTS
  • 20.18 ELIXINOL GLOBAL LIMITED
    • 20.18.1 COMPANY SNAPSHOT
    • 20.18.2 REVENUE ANALYSIS
    • 20.18.3 PRODUCT PORTFOLIO
    • 20.18.4 RECENT DEVELOPMENTS
  • 20.19 ENDOCA
    • 20.19.1 COMPANY SNAPSHOT
    • 20.19.2 PRODUCT PORTFOLIO
    • 20.19.3 RECENT DEVELOPMENT
  • 20.20 EXTRACTAS
    • 20.20.1 COMPANY SNAPSHOT
    • 20.20.2 PRODUCT PORTFOLIO
    • 20.20.3 RECENT DEVELOPMENT
  • 20.21 FOLIUM BIOSCIENCES
    • 20.21.1 COMPANY SNAPSHOT
    • 20.21.2 PRODUCT PORTFOLIO
    • 20.21.3 RECENT DEVELOPMENTS
  • 20.22 GREENWICH BIOSCIENCES, INC.
    • 20.22.1 COMPANY SNAPSHOT
    • 20.22.2 PRODUCT PORTFOLIO
    • 20.22.3 RECENT DEVELOPMENTS
  • 20.23 HARMONY
    • 20.23.1 COMPANY SNAPSHOT
    • 20.23.2 PRODUCT PORTFOLIO
    • 20.23.3 RECENT DEVELOPMENTS
  • 20.24 HUMBOLDT SEED COMPANY
    • 20.24.1 COMPANY SNAPSHOT
    • 20.24.2 PRODUCT PORTFOLIO
    • 20.24.3 RECENT DEVELOPMENT
  • 20.25 IDT AUSTRALIA
    • 20.25.1 COMPANY SNAPSHOT
    • 20.25.2 REVENUE ANALYSIS
    • 20.25.3 PRODUCT PORTFOLIO
    • 20.25.4 RECENT DEVELOPMENTS
  • 20.26 KIEHL'S (A SUBSIDIARY OF L'OREAL)
    • 20.26.1 COMPANY SNAPSHOT
    • 20.26.2 REVENUE ANALYSIS
    • 20.26.3 PRODUCT PORTFOLIO
    • 20.26.4 RECENT DEVELOPMENT
  • 20.27 MARY'S NUTRITIONALS, LLC
    • 20.27.1 COMPANY SNAPSHOT
    • 20.27.2 PRODUCT PORTFOLIO
    • 20.27.3 RECENT DEVELOPMENT
  • 20.28 MEDICAL MARIJUANA, INC.
    • 20.28.1 COMPANY SNAPSHOT
    • 20.28.2 REVENUE ANALYSIS
    • 20.28.3 PRODUCT PORTFOLIO
    • 20.28.4 RECENT DEVELOPMENTS
  • 20.29 MEDIFARM
    • 20.29.1 COMPANY SNAPSHOT
    • 20.29.2 PRODUCT PORTFOLIO
    • 20.29.3 RECENT DEVELOPMENT
  • 20.30 PACIFIC ROOTS
    • 20.30.1 COMPANY SNAPSHOT
    • 20.30.2 PRODUCT PORTFOLIO
    • 20.30.3 RECENT DEVELOPMENT
  • 20.31 PHARMAHEMP
    • 20.31.1 COMPANY SNAPSHOT
    • 20.31.2 PRODUCT PORTFOLIO
    • 20.31.3 RECENT DEVELOPMENT
  • 20.32 PURE RATIOS
    • 20.32.1 COMPANY SNAPSHOT
    • 20.32.2 PRODUCT PORTFOLIO
    • 20.32.3 RECENT DEVELOPMENT
  • 20.33 PEACE NATURALS PROJECT INC.
    • 20.33.1 COMPANY SNAPSHOT
    • 20.33.2 PRODUCT PORTFOLIO
    • 20.33.3 RECENT DEVELOPMENT
  • 20.34 SEED CELLAR
    • 20.34.1 COMPANY SNAPSHOT
    • 20.34.2 PRODUCT PORTFOLIO
    • 20.34.3 RECENT DEVELOPMENT
  • 20.35 SEEDS FOR ME
    • 20.35.1 COMPANY SNAPSHOT
    • 20.35.2 PRODUCT PORTFOLIO
    • 20.35.3 RECENT DEVELOPMENT
  • 20.36 THC GLOBAL GROUP LIMITED
    • 20.36.1 COMPANY SNAPSHOT
    • 20.36.2 REVENUE ANALYSIS
    • 20.36.3 PRODUCT PORTFOLIO
    • 20.36.4 RECENT DEVELOPMENTS
  • 20.37 UPSTATE ELEVATOR SUPPLY CO.
    • 20.37.1 COMPANY SNAPSHOT
    • 20.37.2 PRODUCT PORTFOLIO
    • 20.37.3 RECENT DEVELOPMENT
  • 20.38 VERMONT HEMP HEALTH
    • 20.38.1 COMPANY SNAPSHOT
    • 20.38.2 PRODUCT PORTFOLIO
    • 20.38.3 RECENT DEVELOPMENT

21 QUESTIONNAIRE

22 RELATED REPORTS

LIST OF TABLES

  • TABLE 1 ANNUAL COST OF CULTIVATION:
  • TABLE 2 ANNUAL COST OF MANUFACTURING:
  • TABLE 3 NEUROLOGICAL CONDITIONS FOR WHICH CANNABIS-BASED TREATMENTS HAVE BEEN EMPLOYED
  • TABLE 26 GLOBAL MEDICAL CANNABIS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 27 GLOBAL PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PAIN MANAGEMENT, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 28 GLOBAL PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET , BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 29 GLOBAL PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY ANXIETY, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 30 GLOBAL PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET , BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 31 GLOBAL MUSCLE SPASMS IN MEDICAL CANNABIS MARKET, BY PAIN MANAGEMENT, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 32 GLOBAL MUSCLE SPASMS IN MEDICAL CANNABIS MARKET , BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 33 GLOBAL NAUSEA IN MEDICAL CANNABIS MARKET, BY PAIN MANAGEMENT, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 34 GLOBAL NAUSEA IN MEDICAL CANNABIS MARKET , BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 35 GLOBAL APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY PAIN MANAGEMENT, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 36 GLOBAL APPETITE LOSS IN MEDICAL CANNABIS MARKET , BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 37 GLOBAL CANCER IN MEDICAL CANNABIS MARKET, BY PAIN MANAGEMENT, BY REGION, 2021-2028 (USD MILLION
  • TABLE 38 GLOBAL CANCER IN MEDICAL CANNABIS MARKET , BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 39 GLOBAL ARTHRITIS IN MEDICAL CANNABIS MARKET, BY PAIN MANAGEMENT, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 40 GLOBAL ARTHRITIS IN MEDICAL CANNABIS MARKET , BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 41 GLOBAL ALZHEIMER'S DISEASE/MIGRANES IN MEDICAL CANNABIS MARKET, BY PAIN MANAGEMENT, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 42 GLOBAL ALZHEIMER'S DISEASE/MIGRANES IN MEDICAL CANNABIS MARKET , BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 43 GLOBAL EPILEPSY IN MEDICAL CANNABIS MARKET, BY PAIN MANAGEMENT, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 44 GLOBAL EPILEPSY IN MEDICAL CANNABIS MARKET , BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 45 GLOBAL DEPRESSION AND SLEEP DISORDERS IN MEDICAL CANNABIS MARKET, BY PAIN MANAGEMENT, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 46 GLOBAL DEPRESSION AND SLEEP DISORDERS IN MEDICAL CANNABIS MARKET , BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 47 GLOBAL MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY PAIN MANAGEMENT, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 48 GLOBAL MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET , BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 49 GLOBAL AUTISM IN MEDICAL CANNABIS MARKET, BY PAIN MANAGEMENT, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 50 GLOBAL AUTISM IN MEDICAL CANNABIS MARKET , BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 51 GLOBAL MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PAIN MANAGEMENT, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 52 GLOBAL MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET , BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 53 GLOBAL ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY PAIN MANAGEMENT, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 54 GLOBAL ELEVATE MOOD IN MEDICAL CANNABIS MARKET , BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 55 GLOBAL OTHERS IN MEDICAL CANNABIS MARKET, BY PAIN MANAGEMENT, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 65 GLOBAL MEDICAL CANNABIS MARKET, BY SOURCE, 2019-2028 (USD MILLION)
  • TABLE 66 GLOBAL NATURAL IN MEDICAL CANNABIS MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 67 GLOBAL SYNTHETIC IN MEDICAL CANNABIS MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 68 GLOBAL MEDICAL CANNABIS MARKET, BY SPECIES, 2019-2028 (USD MILLION)
  • TABLE 69 GLOBAL SATIVA IN MEDICAL CANNABIS MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 70 GLOBAL HYBRID IN MEDICAL CANNABIS MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 71 GLOBAL CANNABIS INDICA IN MEDICAL CANNABIS MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 72 GLOBAL MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)
  • TABLE 73 GLOBAL ORAL SOLUTIONS AND CAPSULES IN MEDICAL CANNABIS MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 74 GLOBAL SMOKING IN MEDICAL CANNABIS MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 75 GLOBAL TOPICALS IN MEDICAL CANNABIS MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 76 GLOBAL VAPORIZERS IN MEDICAL CANNABIS MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 77 GLOBAL OTHERS IN MEDICAL CANNABIS MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 78 GLOBAL MEDICAL CANNABIS MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 79 GLOBAL HOMECARE SETTING IN MEDICAL CANNABIS MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 80 GLOBAL HOSPITAL IN MEDICAL CANNABIS MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 81 GLOBAL REHAB CENTERS IN MEDICAL CANNABIS MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 82 GLOBAL PHARMACEUTICAL INDUSTRY IN MEDICAL CANNABIS MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 83 GLOBAL RESEARCH AND DEVELOPMENT CENTERS IN MEDICAL CANNABIS MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 84 GLOBAL OTHERS IN MEDICAL CANNABIS MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 85 GLOBAL MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 86 GLOBAL B2C IN MEDICAL CANNABIS MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 87 GLOBAL B2B IN MEDICAL CANNABIS MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 88 GLOBAL B2B IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 89 GLOBAL MEDICAL CANNABIS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 90 NORTH AMERICA MEDICAL CANNABIS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 91 NORTH AMERICA MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 92 NORTH AMERICA TYPE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 93 NORTH AMERICA SOURCE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 94 NORTH AMERICA SPECIES IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 95 NORTH AMERICA DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 96 NORTH AMERICA TYPE IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 97 NORTH AMERICA CONCENTRATES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 98 NORTH AMERICA SPECIES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 99 NORTH AMERICA VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 100 NORTH AMERICA WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 101 NORTH AMERICA GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 102 NORTH AMERICA MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2028 (USD MILLION)
  • TABLE 103 NORTH AMERICA MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2028 (USD MILLION)
  • TABLE 104 NORTH AMERICA MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 105 NORTH AMERICA CANNABIDIOL (CBD) MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 106 NORTH AMERICA TETRAHYDROCANNABINOL (THC)/DELT-8-TETHYDROCANNABINOL IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 107 NORTH AMERICA CANNABIGEROL (CBG) IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 108 NORTH AMERICA MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 109 NORTH AMERICA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 110 NORTH AMERICA ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 111 NORTH AMERICA MUSCLE SPASMS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 112 NORTH AMERICA NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 113 NORTH AMERICA APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 114 NORTH AMERICA CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 115 NORTH AMERICA ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 116 NORTH AMERICA ALZHEIMER'S DISEASE/MIGRANES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 117 NORTH AMERICA EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 118 NORTH AMERICA DEPRESSION AND SLEEP DISRODER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 119 NORTH AMERICA MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 120 NORTH AMERICA AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 121 NORTH AMERICA MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 122 NORTH AMERICA ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 123 NORTH AMERICA MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (USD MILLION)
  • TABLE 124 NORTH AMERICA MEDICAL CANNABIS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • TABLE 125 NORTH AMERICA MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
  • TABLE 126 NORTH AMERICA B2B IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
  • TABLE 127 U.S. MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 128 U.S. TYPE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 129 U.S. SOURCE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 130 U.S. SPECIES IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 131 U.S. DRIED MEDICAL CANNABS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 132 U.S. TYPE IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 133 U.S. CONCENTRATES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 134 U.S. SPECIES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 135 U.S. VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 136 U.S. WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 137 U.S. GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 138 U.S. MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2028 (USD MILLION)
  • TABLE 139 U.S. MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2028 (USD MILLION)
  • TABLE 140 U.S. MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 141 U.S. CANNABIDIOL (CBD) MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 142 U.S. TETRAHYDROCANNABINOL (THC)/DELT-8-TETHYDROCANNABINOL IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 143 U.S. CANNABIGEROL (CBG) IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 144 U.S. MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 145 U.S. PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 146 U.S. ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 147 U.S. MUSCLE SPASMS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 148 U.S. NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 149 U.S. APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 150 U.S. CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 151 U.S. ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 152 U.S. ALZHEIMER'S DISEASE/MIGRANES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 153 U.S. EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 154 U.S. DEPRESSION AND SLEEP DISRODER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 155 U.S. MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 156 U.S. AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 157 U.S. MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 158 U.S. ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 159 U.S. MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (USD MILLION)
  • TABLE 160 U.S. MEDICAL CANNABIS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • TABLE 161 U.S. MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
  • TABLE 162 U.S. B2B IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
  • TABLE 163 CANADA MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 164 CANADA TYPE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 165 CANADA SOURCE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 166 CANADA SPECIES IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 167 CANADA DRIED MEDICAL CANNABS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 168 CANADA TYPE IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 169 CANADA CONCENTRATES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 170 CANADA SPECIES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 171 CANADA VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 172 CANADA WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 173 CANADA GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 174 CANADA MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2028 (USD MILLION)
  • TABLE 175 CANADA MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2028 (USD MILLION)
  • TABLE 176 CANADA MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 177 CANADA CANNABIDIOL (CBD) MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 178 CANADA TETRAHYDROCANNABINOL (THC)/DELT-8-TETHYDROCANNABINOL IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 179 CANADA CANNABIGEROL (CBG) IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 180 CANADA MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 181 CANADA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 182 CANADA ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 183 CANADA MUSCLE SPASMS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 184 CANADA NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 185 CANADA APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 186 CANADA CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 187 CANADA ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 188 CANADA ALZHEIMER'S DISEASE/MIGRANES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 189 CANADA EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 190 CANADA DEPRESSION AND SLEEP DISRODER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 191 CANADA MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 192 CANADA AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 193 CANADA MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 194 CANADA ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 195 CANADA MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (USD MILLION)
  • TABLE 196 CANADA MEDICAL CANNABIS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • TABLE 197 CANADA MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
  • TABLE 198 CANADA B2B IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
  • TABLE 199 MEXICO MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 200 MEXICO TYPE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 201 MEXICO SOURCE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 202 MEXICO SPECIES IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 203 MEXICO DRIED MEDICAL CANNABS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 204 MEXICO TYPE IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 205 MEXICO CONCENTRATES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 206 MEXICO SPECIES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 207 MEXICO VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 208 MEXICO WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 209 MEXICO GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 210 MEXICO MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2028 (USD MILLION)
  • TABLE 211 MEXICO MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2028 (USD MILLION)
  • TABLE 212 MEXICO MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 213 MEXICO CANNABIDIOL (CBD) MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 214 MEXICO TETRAHYDROCANNABINOL (THC)/DELT-8-TETHYDROCANNABINOL IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 215 MEXICO CANNABIGEROL (CBG) IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 216 MEXICO MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 217 MEXICO PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 218 MEXICO ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 219 MEXICO MUSCLE SPASMS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 220 MEXICO NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 221 MEXICO APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 222 MEXICO CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 223 MEXICO ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 224 MEXICO ALZHEIMER'S DISEASE/MIGRANES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 225 MEXICO EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 226 MEXICO DEPRESSION AND SLEEP DISRODER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 227 MEXICO MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 228 MEXICO AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 229 MEXICO MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 230 MEXICO ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 231 MEXICO MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (USD MILLION)
  • TABLE 232 MEXICO MEDICAL CANNABIS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • TABLE 233 MEXICO MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
  • TABLE 234 MEXICO B2B IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
  • TABLE 235 EUROPE MEDICAL CANNABIS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 236 EUROPE MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 237 EUROPE TYPE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 238 EUROPE SOURCE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 239 EUROPE SPECIES IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 240 EUROPE DRIED MEDICAL CANNABS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 241 EUROPE TYPE IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 242 EUROPE CONCENTRATES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 243 EUROPE SPECIES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 244 EUROPE VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 245 EUROPE WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 246 EUROPE GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 247 EUROPE MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2028 (USD MILLION)
  • TABLE 248 EUROPE MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2028 (USD MILLION)
  • TABLE 249 EUROPE MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 250 EUROPE CANNABIDIOL (CBD) MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 251 EUROPE TETRAHYDROCANNABINOL (THC)/DELT-8-TETHYDROCANNABINOL IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 252 EUROPE CANNABIGEROL (CBG) IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 253 EUROPE MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 254 EUROPE PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 255 EUROPE ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 256 EUROPE MUSCLE SPASMS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 257 EUROPE NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 258 EUROPE APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 259 EUROPE CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 260 EUROPE ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 261 EUROPE ALZHEIMER'S DISEASE/MIGRANES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 262 EUROPE EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 263 EUROPE DEPRESSION AND SLEEP DISRODER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 264 EUROPE MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 265 EUROPE AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 266 EUROPE MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 267 EUROPE ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 268 EUROPE MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (USD MILLION)
  • TABLE 269 EUROPE MEDICAL CANNABIS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • TABLE 270 EUROPE MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
  • TABLE 271 EUROPE B2B IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
  • TABLE 272 GERMANY MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 273 GERMANY TYPE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 274 GERMANY SOURCE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 275 GERMANY SPECIES IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 276 GERMANY DRIED MEDICAL CANNABS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 277 GERMANY TYPE IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 278 GERMANY CONCENTRATES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 279 GERMANY SPECIES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 280 GERMANY VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 281 GERMANY WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 282 GERMANY GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 283 GERMANY MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2028 (USD MILLION)
  • TABLE 284 GERMANY MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2028 (USD MILLION)
  • TABLE 285 GERMANY MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 286 GERMANY CANNABIDIOL (CBD) MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 287 GERMANY TETRAHYDROCANNABINOL (THC)/DELT-8-TETHYDROCANNABINOL IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 288 GERMANY CANNABIGEROL (CBG) IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 289 GERMANY MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 290 GERMANY PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 291 GERMANY ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 292 GERMANY MUSCLE SPASMS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 293 GERMANY NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 294 GERMANY APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 295 GERMANY CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 296 GERMANY ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 297 GERMANY ALZHEIMER'S DISEASE/MIGRANES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 298 GERMANY EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 299 GERMANY DEPRESSION AND SLEEP DISRODER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 300 GERMANY MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 301 GERMANY AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 302 GERMANY MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 303 GERMANY ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 304 GERMANY MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (USD MILLION)
  • TABLE 305 GERMANY MEDICAL CANNABIS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • TABLE 306 GERMANY MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
  • TABLE 307 GERMANY B2B IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
  • TABLE 308 ITALY MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 309 ITALY TYPE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 310 ITALY SOURCE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 311 ITALY SPECIES IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 312 ITALY DRIED MEDICAL CANNABS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 313 ITALY TYPE IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 314 ITALY CONCENTRATES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 315 ITALY SPECIES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 316 ITALY VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 317 ITALY WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 318 ITALY GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 319 ITALY MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2028 (USD MILLION)
  • TABLE 320 ITALY MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2028 (USD MILLION)
  • TABLE 321 ITALY MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 322 ITALY CANNABIDIOL (CBD) MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 323 ITALY TETRAHYDROCANNABINOL (THC)/DELT-8-TETHYDROCANNABINOL IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 324 ITALY CANNABIGEROL (CBG) IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 325 ITALY MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 326 ITALY PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 327 ITALY ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 328 ITALY MUSCLE SPASMS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 329 ITALY NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 330 ITALY APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 331 ITALY CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 332 ITALY ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 333 ITALY ALZHEIMER'S DISEASE/MIGRANES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 334 ITALY EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 335 ITALY DEPRESSION AND SLEEP DISRODER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 336 ITALY MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 337 ITALY AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 338 ITALY MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 339 ITALY ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 340 ITALY MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (USD MILLION)
  • TABLE 341 ITALY MEDICAL CANNABIS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • TABLE 342 ITALY MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
  • TABLE 343 ITALY B2B IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
  • TABLE 344 U.K. MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 345 U.K. TYPE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 346 U.K. SOURCE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 347 U.K. SPECIES IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 348 U.K. DRIED MEDICAL CANNABS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 349 U.K. TYPE IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 350 U.K. CONCENTRATES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 351 U.K. SPECIES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 352 U.K. VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 353 U.K. WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 354 U.K. GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 355 U.K. MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2028 (USD MILLION)
  • TABLE 356 U.K. MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2028 (USD MILLION)
  • TABLE 357 U.K. MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 358 U.K. CANNABIDIOL (CBD) MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 359 U.K. TETRAHYDROCANNABINOL (THC)/DELT-8-TETHYDROCANNABINOL IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 360 U.K. CANNABIGEROL (CBG) IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 361 U.K. MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 362 U.K. PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 363 U.K. ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 364 U.K. MUSCLE SPASMS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 365 U.K. NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 366 U.K. APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 367 U.K. CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 368 U.K. ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 369 U.K. ALZHEIMER'S DISEASE/MIGRANES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 370 U.K. EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 371 U.K. DEPRESSION AND SLEEP DISRODER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 372 U.K. MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 373 U.K. AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 374 U.K. MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 375 U.K. ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 376 U.K. MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (USD MILLION)
  • TABLE 377 U.K. MEDICAL CANNABIS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • TABLE 378 U.K. MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
  • TABLE 379 U.K. B2B IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
  • TABLE 380 NETHERLANDS MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 381 NETHERLANDS TYPE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 382 NETHERLANDS SOURCE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 383 NETHERLANDS SPECIES IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 384 NETHERLANDS DRIED MEDICAL CANNABS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 385 NETHERLANDS TYPE IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 386 NETHERLANDS CONCENTRATES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 387 NETHERLANDS SPECIES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 388 NETHERLANDS VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 389 NETHERLANDS WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 390 NETHERLANDS GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 391 NETHERLANDS MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2028 (USD MILLION)
  • TABLE 392 NETHERLANDS MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2028 (USD MILLION)
  • TABLE 393 NETHERLANDS MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 394 NETHERLANDS CANNABIDIOL (CBD) MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 395 NETHERLANDS TETRAHYDROCANNABINOL (THC)/DELT-8-TETHYDROCANNABINOL IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 396 NETHERLANDS CANNABIGEROL (CBG) IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 397 NETHERLANDS MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 398 NETHERLANDS PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 399 NETHERLANDS ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 400 NETHERLANDS MUSCLE SPASMS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 401 NETHERLANDS NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 402 NETHERLANDS APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 403 NETHERLANDS CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 404 NETHERLANDS ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 405 NETHERLANDS ALZHEIMER'S DISEASE/MIGRANES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 406 NETHERLANDS EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 407 NETHERLANDS DEPRESSION AND SLEEP DISRODER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 408 NETHERLANDS MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 409 NETHERLANDS AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 410 NETHERLANDS MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 411 NETHERLANDS ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 412 NETHERLANDS MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (USD MILLION)
  • TABLE 413 NETHERLANDS MEDICAL CANNABIS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • TABLE 414 NETHERLANDS MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
  • TABLE 415 NETHERLANDS B2B IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
  • TABLE 416 SWITZERLAND MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 417 SWITZERLAND TYPE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 418 SWITZERLAND SOURCE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 419 SWITZERLAND SPECIES IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 420 SWITZERLAND DRIED MEDICAL CANNABS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 421 SWITZERLAND TYPE IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 422 SWITZERLAND CONCENTRATES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 423 SWITZERLAND SPECIES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 424 SWITZERLAND VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 425 SWITZERLAND WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 426 SWITZERLAND GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 427 SWITZERLAND MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2028 (USD MILLION)
  • TABLE 428 SWITZERLAND MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2028 (USD MILLION)
  • TABLE 429 SWITZERLAND MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 430 SWITZERLAND CANNABIDIOL (CBD) MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 431 SWITZERLAND TETRAHYDROCANNABINOL (THC)/DELT-8-TETHYDROCANNABINOL IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 432 SWITZERLAND CANNABIGEROL (CBG) IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 433 SWITZERLAND MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 434 SWITZERLAND PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 435 SWITZERLAND ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 436 SWITZERLAND MUSCLE SPASMS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 437 SWITZERLAND NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 438 SWITZERLAND APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 439 SWITZERLAND CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 440 SWITZERLAND ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 441 SWITZERLAND ALZHEIMER'S DISEASE/MIGRANES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 442 SWITZERLAND EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 443 SWITZERLAND DEPRESSION AND SLEEP DISRODER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 444 SWITZERLAND MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 445 SWITZERLAND AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 446 SWITZERLAND MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 447 SWITZERLAND ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 448 SWITZERLAND MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (USD MILLION)
  • TABLE 449 SWITZERLAND MEDICAL CANNABIS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • TABLE 450 SWITZERLAND MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
  • TABLE 451 SWITZERLAND B2B IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
  • TABLE 452 FRANCE MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 453 FRANCE TYPE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 454 FRANCE SOURCE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 455 FRANCE SPECIES IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 456 FRANCE DRIED MEDICAL CANNABS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 457 FRANCE TYPE IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 458 FRANCE CONCENTRATES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 459 FRANCE SPECIES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 460 FRANCE VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 461 FRANCE WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 462 FRANCE GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 463 FRANCE MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2028 (USD MILLION)
  • TABLE 464 FRANCE MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2028 (USD MILLION)
  • TABLE 465 FRANCE MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 466 FRANCE CANNABIDIOL (CBD) MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 467 FRANCE TETRAHYDROCANNABINOL (THC)/DELT-8-TETHYDROCANNABINOL IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 468 FRANCE CANNABIGEROL (CBG) IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 469 FRANCE MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 470 FRANCE PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 471 FRANCE ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 472 FRANCE MUSCLE SPASMS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 473 FRANCE NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 474 FRANCE APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 475 FRANCE CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 476 FRANCE ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 477 FRANCE ALZHEIMER'S DISEASE/MIGRANES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 478 FRANCE EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 479 FRANCE DEPRESSION AND SLEEP DISRODER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 480 FRANCE MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 481 FRANCE AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 482 FRANCE MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 483 FRANCE ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 484 FRANCE MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (USD MILLION)
  • TABLE 485 FRANCE MEDICAL CANNABIS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • TABLE 486 FRANCE MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
  • TABLE 487 FRANCE B2B IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
  • TABLE 488 RUSSIA MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 489 RUSSIA TYPE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 490 RUSSIA SOURCE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 491 RUSSIA SPECIES IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 492 RUSSIA DRIED MEDICAL CANNABS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 493 RUSSIA TYPE IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 494 RUSSIA CONCENTRATES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 495 RUSSIA SPECIES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 496 RUSSIA VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 497 RUSSIA WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 498 RUSSIA GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 499 RUSSIA MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2028 (USD MILLION)
  • TABLE 500 RUSSIA MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2028 (USD MILLION)
  • TABLE 501 RUSSIA MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 502 RUSSIA CANNABIDIOL (CBD) MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 503 RUSSIA TETRAHYDROCANNABINOL (THC)/DELT-8-TETHYDROCANNABINOL IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 504 RUSSIA CANNABIGEROL (CBG) IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 505 RUSSIA MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 506 RUSSIA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 507 RUSSIA ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 508 RUSSIA MUSCLE SPASMS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 509 RUSSIA NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 510 RUSSIA APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 511 RUSSIA CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 512 RUSSIA ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 513 RUSSIA ALZHEIMER'S DISEASE/MIGRANES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 514 RUSSIA EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 515 RUSSIA DEPRESSION AND SLEEP DISRODER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 516 RUSSIA MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 517 RUSSIA AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 518 RUSSIA MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 519 RUSSIA ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 520 RUSSIA MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (USD MILLION)
  • TABLE 521 RUSSIA MEDICAL CANNABIS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • TABLE 522 RUSSIA MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
  • TABLE 523 RUSSIA B2B IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
  • TABLE 524 SPAIN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 525 SPAIN TYPE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 526 SPAIN SOURCE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 527 SPAIN SPECIES IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 528 SPAIN DRIED MEDICAL CANNABS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 529 SPAIN TYPE IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 530 SPAIN CONCENTRATES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 531 SPAIN SPECIES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 532 SPAIN VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 533 SPAIN WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 534 SPAIN GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 535 SPAIN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2028 (USD MILLION)
  • TABLE 536 SPAIN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2028 (USD MILLION)
  • TABLE 537 SPAIN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 538 SPAIN CANNABIDIOL (CBD) MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 539 SPAIN TETRAHYDROCANNABINOL (THC)/DELT-8-TETHYDROCANNABINOL IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 540 SPAIN CANNABIGEROL (CBG) IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 541 SPAIN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 542 SPAIN PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 543 SPAIN ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 544 SPAIN MUSCLE SPASMS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 545 SPAIN NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 546 SPAIN APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 547 SPAIN CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 548 SPAIN ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 549 SPAIN ALZHEIMER'S DISEASE/MIGRANES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 550 SPAIN EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 551 SPAIN DEPRESSION AND SLEEP DISRODER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 552 SPAIN MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 553 SPAIN AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 554 SPAIN MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 555 SPAIN ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 556 SPAIN MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (USD MILLION)
  • TABLE 557 SPAIN MEDICAL CANNABIS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • TABLE 558 SPAIN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
  • TABLE 559 SPAIN B2B IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
  • TABLE 560 BELGIUM MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 561 BELGIUM TYPE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 562 BELGIUM SOURCE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 563 BELGIUM SPECIES IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 564 BELGIUM DRIED MEDICAL CANNABS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 565 BELGIUM TYPE IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 566 BELGIUM CONCENTRATES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 567 BELGIUM SPECIES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 568 BELGIUM VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 569 BELGIUM WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 570 BELGIUM GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 571 BELGIUM MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2028 (USD MILLION)
  • TABLE 572 BELGIUM MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2028 (USD MILLION)
  • TABLE 573 BELGIUM MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 574 BELGIUM CANNABIDIOL (CBD) MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 575 BELGIUM TETRAHYDROCANNABINOL (THC)/DELT-8-TETHYDROCANNABINOL IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 576 BELGIUM CANNABIGEROL (CBG) IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 577 BELGIUM MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 578 BELGIUM PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 579 BELGIUM ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 580 BELGIUM MUSCLE SPASMS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 581 BELGIUM NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 582 BELGIUM APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 583 BELGIUM CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 584 BELGIUM ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 585 BELGIUM ALZHEIMER'S DISEASE/MIGRANES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 586 BELGIUM EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 587 BELGIUM DEPRESSION AND SLEEP DISRODER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 588 BELGIUM MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 589 BELGIUM AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 590 BELGIUM MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 591 BELGIUM ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 592 BELGIUM MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (USD MILLION)
  • TABLE 593 BELGIUM MEDICAL CANNABIS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • TABLE 594 BELGIUM MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
  • TABLE 595 BELGIUM B2B IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
  • TABLE 596 REST OF EUROPE MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 597 ASIA-PACIFIC MEDICAL CANNABIS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 598 ASIA-PACIFIC MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 599 ASIA-PACIFIC TYPE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 600 ASIA-PACIFIC SOURCE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 601 ASIA-PACIFIC SPECIES IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 602 ASIA-PACIFIC DRIED MEDICAL CANNABS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 603 ASIA-PACIFIC TYPE IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 604 ASIA-PACIFIC CONCENTRATES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 605 ASIA-PACIFIC SPECIES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 606 ASIA-PACIFIC VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 607 ASIA-PACIFIC WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 608 ASIA-PACIFIC GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 609 ASIA-PACIFIC MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2028 (USD MILLION)
  • TABLE 610 ASIA-PACIFIC MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2028 (USD MILLION)
  • TABLE 611 ASIA-PACIFIC MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 612 ASIA-PACIFIC CANNABIDIOL (CBD) MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 613 ASIA-PACIFIC TETRAHYDROCANNABINOL (THC)/DELT-8-TETHYDROCANNABINOL IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 614 ASIA-PACIFIC CANNABIGEROL (CBG) IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 615 ASIA-PACIFIC MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 616 ASIA-PACIFIC PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 617 ASIA-PACIFIC ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 618 ASIA-PACIFIC MUSCLE SPASMS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 619 ASIA-PACIFIC NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 620 ASIA-PACIFIC APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 621 ASIA-PACIFIC CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 622 ASIA-PACIFIC ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 623 ASIA-PACIFIC ALZHEIMER'S DISEASE/MIGRANES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 624 ASIA-PACIFIC EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 625 ASIA-PACIFIC DEPRESSION AND SLEEP DISRODER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 626 ASIA-PACIFIC MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 627 ASIA-PACIFIC AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 628 ASIA-PACIFIC MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 629 ASIA-PACIFIC ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 630 ASIA-PACIFIC MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (USD MILLION)
  • TABLE 631 ASIA-PACIFIC MEDICAL CANNABIS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • TABLE 632 ASIA-PACIFIC MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
  • TABLE 633 ASIA-PACIFIC B2B IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
  • TABLE 634 AUSTRALIA MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 635 AUSTRALIA TYPE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 636 AUSTRALIA SOURCE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 637 AUSTRALIA SPECIES IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 638 AUSTRALIA DRIED MEDICAL CANNABS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 639 AUSTRALIA TYPE IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 640 AUSTRALIA CONCENTRATES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 641 AUSTRALIA SPECIES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 642 AUSTRALIA VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 643 AUSTRALIA WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 644 AUSTRALIA GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 645 AUSTRALIA MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2028 (USD MILLION)
  • TABLE 646 AUSTRALIA MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2028 (USD MILLION)
  • TABLE 647 AUSTRALIA MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 648 AUSTRALIA CANNABIDIOL (CBD) MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 649 AUSTRALIA TETRAHYDROCANNABINOL (THC)/DELT-8-TETHYDROCANNABINOL IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 650 AUSTRALIA CANNABIGEROL (CBG) IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 651 AUSTRALIA MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 652 AUSTRALIA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 653 AUSTRALIA ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 654 AUSTRALIA MUSCLE SPASMS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 655 AUSTRALIA NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 656 AUSTRALIA APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 657 AUSTRALIA CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 658 AUSTRALIA ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 659 AUSTRALIA ALZHEIMER'S DISEASE/MIGRANES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 660 AUSTRALIA EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 661 AUSTRALIA DEPRESSION AND SLEEP DISRODER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 662 AUSTRALIA MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 663 AUSTRALIA AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 664 AUSTRALIA MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 665 AUSTRALIA ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 666 AUSTRALIA MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (USD MILLION)
  • TABLE 667 AUSTRALIA MEDICAL CANNABIS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • TABLE 668 AUSTRALIA MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
  • TABLE 669 AUSTRALIA B2B IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
  • TABLE 670 THAILAND MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 671 THAILAND TYPE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 672 THAILAND SOURCE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 673 THAILAND SPECIES IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 674 THAILAND DRIED MEDICAL CANNABS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 675 THAILAND TYPE IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 676 THAILAND CONCENTRATES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 677 THAILAND SPECIES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 678 THAILAND VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 679 THAILAND WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 680 THAILAND GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 681 THAILAND MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2028 (USD MILLION)
  • TABLE 682 THAILAND MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2028 (USD MILLION)
  • TABLE 683 THAILAND MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 684 THAILAND CANNABIDIOL (CBD) MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 685 THAILAND TETRAHYDROCANNABINOL (THC)/DELT-8-TETHYDROCANNABINOL IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 686 THAILAND CANNABIGEROL (CBG) IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 687 THAILAND MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 688 THAILAND PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 689 THAILAND ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 690 THAILAND MUSCLE SPASMS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 691 THAILAND NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 692 THAILAND APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 693 THAILAND CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 694 THAILAND ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 695 THAILAND ALZHEIMER'S DISEASE/MIGRANES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 696 THAILAND EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 697 THAILAND DEPRESSION AND SLEEP DISRODER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 698 THAILAND MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 699 THAILAND AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 700 THAILAND MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 701 THAILAND ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 702 THAILAND MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (USD MILLION)
  • TABLE 703 THAILAND MEDICAL CANNABIS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • TABLE 704 THAILAND MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
  • TABLE 705 THAILAND B2B IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
  • TABLE 706 SOUTH KOREA MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 707 SOUTH KOREA TYPE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 708 SOUTH KOREA SOURCE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 709 SOUTH KOREA SPECIES IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 710 SOUTH KOREA DRIED MEDICAL CANNABS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 711 SOUTH KOREA TYPE IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 712 SOUTH KOREA CONCENTRATES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 713 SOUTH KOREA SPECIES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 714 SOUTH KOREA VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 715 SOUTH KOREA WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 716 SOUTH KOREA GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 717 SOUTH KOREA MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2028 (USD MILLION)
  • TABLE 718 SOUTH KOREA MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2028 (USD MILLION)
  • TABLE 719 SOUTH KOREA MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 720 SOUTH KOREA CANNABIDIOL (CBD) MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 721 SOUTH KOREA TETRAHYDROCANNABINOL (THC)/DELT-8-TETHYDROCANNABINOL IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 722 SOUTH KOREA CANNABIGEROL (CBG) IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 723 SOUTH KOREA MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 724 SOUTH KOREA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 725 SOUTH KOREA ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 726 SOUTH KOREA MUSCLE SPASMS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 727 SOUTH KOREA NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 728 SOUTH KOREA APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 729 SOUTH KOREA CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 730 SOUTH KOREA ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 731 SOUTH KOREA ALZHEIMER'S DISEASE/MIGRANES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 732 SOUTH KOREA EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 733 SOUTH KOREA DEPRESSION AND SLEEP DISRODER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 734 SOUTH KOREA MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 735 SOUTH KOREA AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 736 SOUTH KOREA MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 737 SOUTH KOREA ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 738 SOUTH KOREA MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (USD MILLION)
  • TABLE 739 SOUTH KOREA MEDICAL CANNABIS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • TABLE 740 SOUTH KOREA MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
  • TABLE 741 SOUTH KOREA B2B IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
  • TABLE 742 JAPAN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 743 JAPAN TYPE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 744 JAPAN SOURCE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 745 JAPAN SPECIES IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 746 JAPAN DRIED MEDICAL CANNABS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 747 JAPAN TYPE IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 748 JAPAN CONCENTRATES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 749 JAPAN SPECIES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 750 JAPAN VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 751 JAPAN WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 752 JAPAN GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 753 JAPAN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2028 (USD MILLION)
  • TABLE 754 JAPAN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2028 (USD MILLION)
  • TABLE 755 JAPAN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 756 JAPAN CANNABIDIOL (CBD) MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 757 JAPAN TETRAHYDROCANNABINOL (THC)/DELT-8-TETHYDROCANNABINOL IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 758 JAPAN CANNABIGEROL (CBG) IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 759 JAPAN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 760 JAPAN PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 761 JAPAN ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 762 JAPAN MUSCLE SPASMS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 763 JAPAN NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 764 JAPAN APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 765 JAPAN CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 766 JAPAN ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 767 JAPAN ALZHEIMER'S DISEASE/MIGRANES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 768 JAPAN EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 769 JAPAN DEPRESSION AND SLEEP DISRODER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 770 JAPAN MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 771 JAPAN AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 772 JAPAN MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 773 JAPAN ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 774 JAPAN MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (USD MILLION)
  • TABLE 775 JAPAN MEDICAL CANNABIS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • TABLE 776 JAPAN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
  • TABLE 777 JAPAN B2B IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
  • TABLE 778 CHINA MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 779 CHINA TYPE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 780 CHINA SOURCE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 781 CHINA SPECIES IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 782 CHINA DRIED MEDICAL CANNABS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 783 CHINA TYPE IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 784 CHINA CONCENTRATES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 785 CHINA SPECIES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 786 CHINA VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 787 CHINA WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 788 CHINA GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 789 CHINA MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2028 (USD MILLION)
  • TABLE 790 CHINA MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2028 (USD MILLION)
  • TABLE 791 CHINA MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 792 CHINA CANNABIDIOL (CBD) MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 793 CHINA TETRAHYDROCANNABINOL (THC)/DELT-8-TETHYDROCANNABINOL IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 794 CHINA CANNABIGEROL (CBG) IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 795 CHINA MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 796 CHINA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 797 CHINA ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 798 CHINA MUSCLE SPASMS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 799 CHINA NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 800 CHINA APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 801 CHINA CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 802 CHINA ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 803 CHINA ALZHEIMER'S DISEASE/MIGRANES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 804 CHINA EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 805 CHINA DEPRESSION AND SLEEP DISRODER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 806 CHINA MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 807 CHINA AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 808 CHINA MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 809 CHINA ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 810 CHINA MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (USD MILLION)
  • TABLE 811 CHINA MEDICAL CANNABIS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • TABLE 812 CHINA MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
  • TABLE 813 CHINA B2B IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
  • TABLE 814 SINGAPORE MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 815 SINGAPORE TYPE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 816 SINGAPORE SOURCE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 817 SINGAPORE SPECIES IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 818 SINGAPORE DRIED MEDICAL CANNABS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 819 SINGAPORE TYPE IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 820 SINGAPORE CONCENTRATES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 821 SINGAPORE SPECIES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 822 SINGAPORE VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 823 SINGAPORE WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 824 SINGAPORE GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 825 SINGAPORE MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2028 (USD MILLION)
  • TABLE 826 SINGAPORE MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2028 (USD MILLION)
  • TABLE 827 SINGAPORE MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 828 SINGAPORE CANNABIDIOL (CBD) MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 829 SINGAPORE TETRAHYDROCANNABINOL (THC)/DELT-8-TETHYDROCANNABINOL IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 830 SINGAPORE CANNABIGEROL (CBG) IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 831 SINGAPORE MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 832 SINGAPORE PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 833 SINGAPORE ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 834 SINGAPORE MUSCLE SPASMS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 835 SINGAPORE NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 836 SINGAPORE APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 837 SINGAPORE CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 838 SINGAPORE ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 839 SINGAPORE ALZHEIMER'S DISEASE/MIGRANES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 840 SINGAPORE EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 841 SINGAPORE DEPRESSION AND SLEEP DISRODER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 842 SINGAPORE MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 843 SINGAPORE AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 844 SINGAPORE MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 845 SINGAPORE ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 846 SINGAPORE MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (USD MILLION)
  • TABLE 847 SINGAPORE MEDICAL CANNABIS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • TABLE 848 SINGAPORE MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
  • TABLE 849 SINGAPORE B2B IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
  • TABLE 850 INDIA MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 851 INDIA TYPE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 852 INDIA SOURCE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 853 INDIA SPECIES IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 854 INDIA DRIED MEDICAL CANNABS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 855 INDIA TYPE IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 856 INDIA CONCENTRATES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 857 INDIA SPECIES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 858 INDIA VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 859 INDIA WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 860 INDIA GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 861 INDIA MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2028 (USD MILLION)
  • TABLE 862 INDIA MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2028 (USD MILLION)
  • TABLE 863 INDIA MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 864 INDIA CANNABIDIOL (CBD) MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 865 INDIA TETRAHYDROCANNABINOL (THC)/DELT-8-TETHYDROCANNABINOL IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 866 INDIA CANNABIGEROL (CBG) IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 867 INDIA MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 868 INDIA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 869 INDIA ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 870 INDIA MUSCLE SPASMS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 871 INDIA NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 872 INDIA APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 873 INDIA CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 874 INDIA ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 875 INDIA ALZHEIMER'S DISEASE/MIGRANES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 876 INDIA EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 877 INDIA DEPRESSION AND SLEEP DISRODER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 878 INDIA MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 879 INDIA AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 880 INDIA MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 881 INDIA ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 882 INDIA MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (USD MILLION)
  • TABLE 883 INDIA MEDICAL CANNABIS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • TABLE 884 INDIA MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
  • TABLE 885 INDIA B2B IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
  • TABLE 886 MALAYSIA MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 887 MALAYSIA TYPE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 888 MALAYSIA SOURCE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 889 MALAYSIA SPECIES IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 890 MALAYSIA DRIED MEDICAL CANNABS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 891 MALAYSIA TYPE IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 892 MALAYSIA CONCENTRATES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 893 MALAYSIA SPECIES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 894 MALAYSIA VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 895 MALAYSIA WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 896 MALAYSIA GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 897 MALAYSIA MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2028 (USD MILLION)
  • TABLE 898 MALAYSIA MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2028 (USD MILLION)
  • TABLE 899 MALAYSIA MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 900 MALAYSIA CANNABIDIOL (CBD) MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 901 MALAYSIA TETRAHYDROCANNABINOL (THC)/DELT-8-TETHYDROCANNABINOL IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 902 MALAYSIA CANNABIGEROL (CBG) IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 903 MALAYSIA MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 904 MALAYSIA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 905 MALAYSIA ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 906 MALAYSIA MUSCLE SPASMS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 907 MALAYSIA NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 908 MALAYSIA APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 909 MALAYSIA CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 910 MALAYSIA ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 911 MALAYSIA ALZHEIMER'S DISEASE/MIGRANES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 912 MALAYSIA EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 913 MALAYSIA DEPRESSION AND SLEEP DISRODER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 914 MALAYSIA MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 915 MALAYSIA AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 916 MALAYSIA MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 917 MALAYSIA ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 918 MALAYSIA MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (USD MILLION)
  • TABLE 919 MALAYSIA MEDICAL CANNABIS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • TABLE 920 MALAYSIA MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
  • TABLE 921 MALAYSIA B2B IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
  • TABLE 922 PHILIPPINES MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 923 PHILIPPINES TYPE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 924 PHILIPPINES SOURCE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 925 PHILIPPINES SPECIES IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 926 PHILIPPINES DRIED MEDICAL CANNABS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 927 PHILIPPINES TYPE IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 928 PHILIPPINES CONCENTRATES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 929 PHILIPPINES SPECIES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 930 PHILIPPINES VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 931 PHILIPPINES WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 932 PHILIPPINES GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 933 PHILIPPINES MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2028 (USD MILLION)
  • TABLE 934 PHILIPPINES MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2028 (USD MILLION)
  • TABLE 935 PHILIPPINES MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 936 PHILIPPINES CANNABIDIOL (CBD) MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 937 PHILIPPINES TETRAHYDROCANNABINOL (THC)/DELT-8-TETHYDROCANNABINOL IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 938 PHILIPPINES CANNABIGEROL (CBG) IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 939 PHILIPPINES MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 940 PHILIPPINES PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 941 PHILIPPINES ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 942 PHILIPPINES MUSCLE SPASMS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 943 PHILIPPINES NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 944 PHILIPPINES APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 945 PHILIPPINES CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 946 PHILIPPINES ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 947 PHILIPPINES ALZHEIMER'S DISEASE/MIGRANES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 948 PHILIPPINES EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 949 PHILIPPINES DEPRESSION AND SLEEP DISRODER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 950 PHILIPPINES MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 951 PHILIPPINES AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 952 PHILIPPINES MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 953 PHILIPPINES ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 954 PHILIPPINES MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (USD MILLION)
  • TABLE 955 PHILIPPINES MEDICAL CANNABIS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • TABLE 956 PHILIPPINES MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
  • TABLE 957 PHILIPPINES B2B IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
  • TABLE 958 REST OF ASIA-PACIFIC MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 959 SOUTH AMERICA MEDICAL CANNABIS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 960 SOUTH AMERICA MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 961 SOUTH AMERICA TYPE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 962 SOUTH AMERICA SOURCE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 963 SOUTH AMERICA SPECIES IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 964 SOUTH AMERICA DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 965 SOUTH AMERICA TYPE IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 966 SOUTH AMERICA CONCENTRATES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 967 SOUTH AMERICA SPECIES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 968 SOUTH AMERICA VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 969 SOUTH AMERICA WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 970 SOUTH AMERICA GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 971 SOUTH AMERICA MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2028 (USD MILLION)
  • TABLE 972 SOUTH AMERICA MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2028 (USD MILLION)
  • TABLE 973 SOUTH AMERICA MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 974 SOUTH AMERICA CANNABIDIOL (CBD) MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 975 SOUTH AMERICA TETRAHYDROCANNABINOL (THC)/DELT-8-TETHYDROCANNABINOL IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 976 SOUTH AMERICA CANNABIGEROL (CBG) IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 977 SOUTH AMERICA MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 978 SOUTH AMERICA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 979 SOUTH AMERICA ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 980 SOUTH AMERICA MUSCLE SPASMS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 981 SOUTH AMERICA NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 982 SOUTH AMERICA APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 983 SOUTH AMERICA CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 984 SOUTH AMERICA ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 985 SOUTH AMERICA ALZHEIMER'S DISEASE/MIGRANES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 986 SOUTH AMERICA EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 987 SOUTH AMERICA DEPRESSION AND SLEEP DISRODER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 988 SOUTH AMERICA MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 989 SOUTH AMERICA AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 990 SOUTH AMERICA MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 991 SOUTH AMERICA ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 992 SOUTH AMERICA MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (USD MILLION)
  • TABLE 993 SOUTH AMERICA MEDICAL CANNABIS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • TABLE 994 SOUTH AMERICA MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
  • TABLE 995 SOUTH AMERICA B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
  • TABLE 996 BRAZIL MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 997 BRAZIL TYPE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 998 BRAZIL SOURCE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 999 BRAZIL SPECIES IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 1000 BRAZIL DRIED MEDICAL CANNABS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 1001 BRAZIL TYPE IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 1002 BRAZIL CONCENTRATES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 1003 BRAZIL SPECIES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 1004 BRAZIL VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 1005 BRAZIL WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 1006 BRAZIL GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 1007 BRAZIL MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2028 (USD MILLION)
  • TABLE 1008 BRAZIL MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2028 (USD MILLION)
  • TABLE 1009 BRAZIL MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 1010 BRAZIL CANNABIDIOL (CBD) MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 1011 BRAZIL TETRAHYDROCANNABINOL (THC)/DELT-8-TETHYDROCANNABINOL IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 1012 BRAZIL CANNABIGEROL (CBG) IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 1013 BRAZIL MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 1014 BRAZIL PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 1015 BRAZIL ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 1016 BRAZIL MUSCLE SPASMS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 1017 BRAZIL NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 1018 BRAZIL APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 1019 BRAZIL CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 1020 BRAZIL ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 1021 BRAZIL ALZHEIMER'S DISEASE/MIGRANES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 1022 BRAZIL EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 1023 BRAZIL DEPRESSION AND SLEEP DISRODER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 1024 BRAZIL MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 1025 BRAZIL AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 1026 BRAZIL MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 1027 BRAZIL ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 1028 BRAZIL MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (USD MILLION)
  • TABLE 1029 BRAZIL MEDICAL CANNABIS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • TABLE 1030 BRAZIL MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
  • TABLE 1031 BRAZIL B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
  • TABLE 1032 ARGENTINA MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 1033 ARGENTINA TYPE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 1034 ARGENTINA SOURCE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 1035 ARGENTINA SPECIES IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 1036 ARGENTINA DRIED MEDICAL CANNABS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 1037 ARGENTINA TYPE IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 1038 ARGENTINA CONCENTRATES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 1039 ARGENTINA SPECIES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 1040 ARGENTINA VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 1041 ARGENTINA WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 1042 ARGENTINA GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 1043 ARGENTINA MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2028 (USD MILLION)
  • TABLE 1044 ARGENTINA MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2028 (USD MILLION)
  • TABLE 1045 ARGENTINA MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 1046 ARGENTINA CANNABIDIOL (CBD) MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 1047 ARGENTINA TETRAHYDROCANNABINOL (THC)/DELT-8-TETHYDROCANNABINOL IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 1048 ARGENTINA CANNABIGEROL (CBG) IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 1049 ARGENTINA MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 1050 ARGENTINA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 1051 ARGENTINA ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 1052 ARGENTINA MUSCLE SPASMS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 1053 ARGENTINA NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 1054 ARGENTINA APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 1055 ARGENTINA CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 1056 ARGENTINA ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 1057 ARGENTINA ALZHEIMER'S DISEASE/MIGRANES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 1058 ARGENTINA EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 1059 ARGENTINA DEPRESSION AND SLEEP DISRODER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 1060 ARGENTINA MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 1061 ARGENTINA AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 1062 ARGENTINA MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 1063 ARGENTINA ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 1064 ARGENTINA MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (USD MILLION)
  • TABLE 1065 ARGENTINA MEDICAL CANNABIS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • TABLE 1066 ARGENTINA MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
  • TABLE 1067 ARGENTINA B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
  • TABLE 1068 REST OF SOUTH AMERICA MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 1069 MIDDLE EAST AND AFRICA MEDICAL CANNABIS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 1070 MIDDLE EAST AND AFRICA MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 1071 MIDDLE EAST AND AFRICA TYPE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 1072 MIDDLE EAST AND AFRICA SOURCE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 1073 MIDDLE EAST AND AFRICA SPECIES IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 1074 MIDDLE EAST AND AFRICA DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 1075 MIDDLE EAST AND AFRICA TYPE IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 1076 MIDDLE EAST AND AFRICA CONCENTRATES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 1077 MIDDLE EAST AND AFRICA SPECIES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 1078 MIDDLE EAST AND AFRICA VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 1079 MIDDLE EAST AND AFRICA WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 1080 MIDDLE EAST AND AFRICA GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 1081 MIDDLE EAST AND AFRICA MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2028 (USD MILLION)
  • TABLE 1082 MIDDLE EAST AND AFRICA MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2028 (USD MILLION)
  • TABLE 1083 MIDDLE EAST AND AFRICA MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 1084 MIDDLE EAST AND AFRICA CANNABIDIOL (CBD) MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 1085 MIDDLE EAST AND AFRICA TETRAHYDROCANNABINOL (THC)/DELT-8-TETHYDROCANNABINOL IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 1086 MIDDLE EAST AND AFRICA CANNABIGEROL (CBG) IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 1087 MIDDLE EAST AND AFRICA MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 1088 MIDDLE EAST AND AFRICA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 1089 MIDDLE EAST AND AFRICA ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 1090 MIDDLE EAST AND AFRICA MUSCLE SPASMS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 1091 MIDDLE EAST AND AFRICA NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 1092 MIDDLE EAST AND AFRICA APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 1093 MIDDLE EAST AND AFRICA CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 1094 MIDDLE EAST AND AFRICA ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 1095 MIDDLE EAST AND AFRICA ALZHEIMER'S DISEASE/MIGRANES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 1096 MIDDLE EAST AND AFRICA EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 1097 MIDDLE EAST AND AFRICA DEPRESSION AND SLEEP DISRODER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 1098 MIDDLE EAST AND AFRICA MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 1099 MIDDLE EAST AND AFRICA AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 1100 MIDDLE EAST AND AFRICA MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 1101 MIDDLE EAST AND AFRICA ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 1102 MIDDLE EAST AND AFRICA MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (USD MILLION)
  • TABLE 1103 MIDDLE EAST AND AFRICA MEDICAL CANNABIS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • TABLE 1104 MIDDLE EAST AND AFRICA MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
  • TABLE 1105 MIDDLE EAST AND AFRICA B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
  • TABLE 1106 ISRAEL MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 1107 ISRAEL TYPE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 1108 ISRAEL SOURCE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 1109 ISRAEL SPECIES IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 1110 ISRAEL DRIED MEDICAL CANNABS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 1111 ISRAEL TYPE IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 1112 ISRAEL CONCENTRATES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 1113 ISRAEL SPECIES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 1114 ISRAEL VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 1115 ISRAEL WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 1116 ISRAEL GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 1117 ISRAEL MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2028 (USD MILLION)
  • TABLE 1118 ISRAEL MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2028 (USD MILLION)
  • TABLE 1119 ISRAEL MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 1120 ISRAEL CANNABIDIOL (CBD) MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 1121 ISRAEL TETRAHYDROCANNABINOL (THC)/DELT-8-TETHYDROCANNABINOL IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 1122 ISRAEL CANNABIGEROL (CBG) IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 1123 ISRAEL MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 1124 ISRAEL PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 1125 ISRAEL ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 1126 ISRAEL MUSCLE SPASMS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 1127 ISRAEL NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 1128 ISRAEL APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 1129 ISRAEL CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 1130 ISRAEL ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 1131 ISRAEL ALZHEIMER'S DISEASE/MIGRANES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 1132 ISRAEL EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 1133 ISRAEL DEPRESSION AND SLEEP DISRODER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 1134 ISRAEL MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 1135 ISRAEL AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 1136 ISRAEL MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 1137 ISRAEL ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 1138 ISRAEL MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (USD MILLION)
  • TABLE 1139 ISRAEL MEDICAL CANNABIS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • TABLE 1140 ISRAEL MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
  • TABLE 1141 ISRAEL B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
  • TABLE 1142 SOUTH AFRICA MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 1143 SOUTH AFRICA TYPE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 1144 SOUTH AFRICA SOURCE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 1145 SOUTH AFRICA SPECIES IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 1146 SOUTH AFRICA DRIED MEDICAL CANNABS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 1147 SOUTH AFRICA TYPE IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 1148 SOUTH AFRICA CONCENTRATES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 1149 SOUTH AFRICA SPECIES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 1150 SOUTH AFRICA VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 1151 SOUTH AFRICA WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 1152 SOUTH AFRICA GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 1153 SOUTH AFRICA MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2028 (USD MILLION)
  • TABLE 1154 SOUTH AFRICA MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2028 (USD MILLION)
  • TABLE 1155 SOUTH AFRICA MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 1156 SOUTH AFRICA CANNABIDIOL (CBD) MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 1157 SOUTH AFRICA TETRAHYDROCANNABINOL (THC)/DELT-8-TETHYDROCANNABINOL IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 1158 SOUTH AFRICA CANNABIGEROL (CBG) IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)
  • TABLE 1159 SOUTH AFRICA MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 1160 SOUTH AFRICA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 1161 SOUTH AFRICA ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 1162 SOUTH AFRICA MUSCLE SPASMS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 1163 SOUTH AFRICA NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 1164 SOUTH AFRICA APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 1165 SOUTH AFRICA CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 1166 SOUTH AFRICA ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 1167 SOUTH AFRICA ALZHEIMER'S DISEASE/MIGRANES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 1168 SOUTH AFRICA EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 1169 SOUTH AFRICA DEPRESSION AND SLEEP DISRODER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 1170 SOUTH AFRICA MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 1171 SOUTH AFRICA AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 1172 SOUTH AFRICA MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 1173 SOUTH AFRICA ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 1174 SOUTH AFRICA MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (USD MILLION)
  • TABLE 1175 SOUTH AFRICA MEDICAL CANNABIS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • TABLE 1176 SOUTH AFRICA MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
  • TABLE 1177 SOUTH AFRICA B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
  • TABLE 1178 REST OF MIDDLE EAST AND AFRICA MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1 GLOBAL MEDICAL CANNABIS MARKET: SEGMENTATION 123
  • FIGURE 2 GLOBAL MEDICAL CANNABIS MARKET: DATA TRIANGULATION 126
  • FIGURE 3 GLOBAL MEDICAL CANNABIS MARKET: DROC ANALYSIS 127
  • FIGURE 4 GLOBAL MEDICAL CANNABIS MARKET : GLOBAL VS REGIONAL MARKET ANALYSIS 128
  • FIGURE 5 GLOBAL MEDICAL CANNABIS MARKET : COMPANY RESEARCH ANALYSIS 128
  • FIGURE 6 GLOBAL MEDICAL CANNABIS MARKET: INTERVIEW DEMOGRAPHICS 130
  • FIGURE 7 GLOBAL MEDICAL CANNABIS MARKET: DBMR MARKET POSITION GRID 131
  • FIGURE 8 GLOBAL MEDICAL CANNABIS MARKET: MARKET APPLICATION COVERAGE GRID 132
  • FIGURE 9 GLOBAL MEDICAL CANNABIS MARKET: VENDOR SHARE ANALYSIS 133
  • FIGURE 10 GLOBAL MEDICAL CANNABIS MARKET: SEGMENTATION 137
  • FIGURE 11 INCREASING MEDICINAL USE AND LEGALIZATION OF MEDICAL CANNABIS ARE EXPECTED TO DRIVE THE GLOBAL MEDICAL CANNABIS MARKET IN THE FORECAST PERIOD OF 2021 TO 2028 138
  • FIGURE 12 OIL SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL MEDICAL CANANBIS MARKET IN 2021 & 2028 138
  • FIGURE 13 NORTH AMERICA IS EXPECTED TO DOMINATE THE GLOBAL MEDICAL CANANBIS MARKET AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2021 TO 2028 139
  • FIGURE 14 ASIA-PACIFIC IS THE FASTEST GROWING MARKET FOR MEDICAL CANNABIS MANUFACTURERS IN THE FORECAST PERIOD OF 2021 TO 2028 140
  • FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF GLOBAL MEDICAL CANNABIS MARKET 147
  • FIGURE 16 GLOBAL MEDICAL CANNABIS MARKET: BY PRODUCT, 2020 159
  • FIGURE 17 GLOBAL MEDICAL CANNABIS MARKET: BY PRODUCT, 2021-2028 (USD MILLION) 160
  • FIGURE 18 GLOBAL MEDICAL CANNABIS MARKET: BY PRODUCT, CAGR (2021-2028) 160
  • FIGURE 19 GLOBAL MEDICAL CANNABIS MARKET: BY PRODUCT, LIFELINE CURVE 161
  • FIGURE 20 GLOBAL MEDICAL CANNABIS MARKET: BY APPLICATION, 2020 176
  • FIGURE 21 GLOBAL MEDICAL CANNABIS MARKET: BY APPLICATION, 2021-2028 (USD MILLION) 177
  • FIGURE 22 GLOBAL MEDICAL CANNABIS MARKET: BY APPLICATION, CAGR (2021-2028) 178
  • FIGURE 23 GLOBAL MEDICAL CANNABIS MARKET: BY APPLICATION, LIFELINE CURVE 178
  • FIGURE 24 GLOBAL MEDICAL CANNABIS MARKET: BY DERIVATIVES, 2020 209
  • FIGURE 25 GLOBAL MEDICAL CANNABIS MARKET: BY DERIVATIVES, 2021-2028 (USD MILLION) 210
  • FIGURE 26 GLOBAL MEDICAL CANNABIS MARKET: BY DERIVATIVES, CAGR (2021-2028) 210
  • FIGURE 27 GLOBAL MEDICAL CANNABIS MARKET: BY DERIVATIVES, LIFELINE CURVE 211
  • FIGURE 28 GLOBAL MEDICAL CANNABIS MARKET: BY SOURCE, 2020 221
  • FIGURE 29 GLOBAL MEDICAL CANNABIS MARKET: BY SOURCE, 2021-2028 (USD MILLION) 222
  • FIGURE 30 GLOBAL MEDICAL CANNABIS MARKET: BY SOURCE, CAGR (2021-2028) 222
  • FIGURE 31 GLOBAL MEDICAL CANNABIS MARKET: BY SOURCE, LIFELINE CURVE 223
  • FIGURE 32 GLOBAL MEDICAL CANNABIS MARKET: BY SPECIES, 2020 227
  • FIGURE 33 GLOBAL MEDICAL CANNABIS MARKET: BY SPECIES, 2021-2028 (USD MILLION) 228
  • FIGURE 34 GLOBAL MEDICAL CANNABIS MARKET: BY SPECIES, CAGR (2021-2028) 228
  • FIGURE 35 GLOBAL MEDICAL CANNABIS MARKET: BY SPECIES, LIFELINE CURVE 229
  • FIGURE 36 GLOBAL MEDICAL CANNABIS MARKET: BY ROUTE OF ADMINISTRATION, 2020 233
  • FIGURE 37 GLOBAL MEDICAL CANNABIS MARKET: BY ROUTE OF ADMINISTRATION, 2021-2028 (USD MILLION) 234
  • FIGURE 38 GLOBAL MEDICAL CANNABIS MARKET: BY ROUTE OF ADMINISTRATION, CAGR (2021-2028) 234
  • FIGURE 39 GLOBAL MEDICAL CANNABIS MARKET: BY ROUTE OF ADMINISTRATION, LIFELINE CURVE 235
  • FIGURE 40 GLOBAL MEDICAL CANNABIS MARKET: BY END USER, 2020 241
  • FIGURE 41 GLOBAL MEDICAL CANNABIS MARKET: BY END USER, 2021-2028 (USD MILLION) 242
  • FIGURE 42 GLOBAL MEDICAL CANNABIS MARKET: BY END USER, CAGR (2021-2028) 242
  • FIGURE 43 GLOBAL MEDICAL CANNABIS MARKET: BY END USER, LIFELINE CURVE 243
  • FIGURE 44 GLOBAL MEDICAL CANNABIS MARKET: BY DISTRIBUTION CHANNEL, 2020 250
  • FIGURE 45 GLOBAL MEDICAL CANNABIS MARKET: BY DISTRIBUTION CHANNEL , 2021-2028 (USD MILLION) 251
  • FIGURE 46 GLOBAL MEDICAL CANNABIS MARKET: BY DISTRIBUTION CHANNEL , CAGR (2021-2028) 251
  • FIGURE 47 GLOBAL MEDICAL CANNABIS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE 252
  • FIGURE 48 GLOBAL MEDICAL CANNABIS MARKET: SNAPSHOT (2020) 256
  • FIGURE 49 GLOBAL MEDICAL CANNABIS MARKET: BY COUNTRY (2020) 258
  • FIGURE 50 GLOBAL MEDICAL CANNABIS MARKET: BY COUNTRY (2021 & 2028) 258
  • FIGURE 51 GLOBAL MEDICAL CANNABIS MARKET: BY COUNTRY (2020 & 2028) 259
  • FIGURE 52 GLOBAL MEDICAL CANNABIS MARKET: BY TYPE (2021-2028) 259
  • FIGURE 53 NORTH AMERICA MEDICAL CANNABIS MARKET: SNAPSHOT (2020) 261
  • FIGURE 54 NORTH AMERICA MEDICAL CANNABIS MARKET: BY COUNTRY (2020) 263
  • FIGURE 55 NORTH AMERICA MEDICAL CANNABIS MARKET: BY COUNTRY (2021 & 2028) 263
  • FIGURE 56 NORTH AMERICA MEDICAL CANNABIS MARKET: BY COUNTRY (2020 & 2028) 264
  • FIGURE 57 NORTH AMERICA MEDICAL CANNABIS MARKET: BY TYPE (2021-2028) 264
  • FIGURE 58 EUROPE MEDICAL CANNABIS MARKET: SNAPSHOT (2020) 320
  • FIGURE 59 EUROPE MEDICAL CANNABIS MARKET: BY COUNTRY (2020) 322
  • FIGURE 60 EUROPE MEDICAL CANNABIS MARKET: BY COUNTRY (2021 & 2028) 322
  • FIGURE 61 EUROPE MEDICAL CANNABIS MARKET: BY COUNTRY (2020 & 2028) 323
  • FIGURE 62 EUROPE MEDICAL CANNABIS MARKET: BY TYPE (2021-2028) 323
  • FIGURE 63 ASIA-PACIFIC MEDICAL CANNABIS MARKET: SNAPSHOT (2020) 464
  • FIGURE 64 ASIA-PACIFIC MEDICAL CANNABIS MARKET: BY COUNTRY (2020) 466
  • FIGURE 65 ASIA-PACIFIC MEDICAL CANNABIS MARKET: BY COUNTRY (2021 & 2028) 466
  • FIGURE 66 ASIA-PACIFIC MEDICAL CANNABIS MARKET: BY COUNTRY (2020 & 2028) 467
  • FIGURE 67 ASIA-PACIFIC MEDICAL CANNABIS MARKET: BY TYPE (2021-2028) 467
  • FIGURE 68 SOUTH AMERICA MEDICAL CANNABIS MARKET: SNAPSHOT (2020) 609
  • FIGURE 69 SOUTH AMERICA MEDICAL CANNABIS MARKET: BY COUNTRY (2020) 611
  • FIGURE 70 SOUTH AMERICA MEDICAL CANNABIS MARKET: BY COUNTRY (2021 & 2028) 611
  • FIGURE 71SOUTH AMERICA MEDICAL CANNABIS MARKET: BY COUNTRY (2020 & 2028) 612
  • FIGURE 72 SOUTH AMERICA MEDICAL CANNABIS MARKET: BY TYPE (2021-2028) 612
  • FIGURE 73 MIDDLE EAST AND AFRICA MEDICAL CANNABIS MARKET: SNAPSHOT (2020) 656
  • FIGURE 74 MIDDLE EAST AND AFRICA MEDICAL CANNABIS MARKET: BY COUNTRY (2020) 658
  • FIGURE 75 MIDDLE EAST AND AFRICA MEDICAL CANNABIS MARKET: BY COUNTRY (2021 & 2028) 658
  • FIGURE 76 MIDDLE EAST AND AFRICA MEDICAL CANNABIS MARKET: BY COUNTRY (2020 & 2028) 659
  • FIGURE 77 MIDDLE EAST AND AFRICA MEDICAL CANNABIS MARKET: BY TYPE (2021-2028) 659
  • FIGURE 78 GLOBAL MEDICAL CANNABIS MARKET: COMPANY SHARE 2020 (%) 704
  • FIGURE 79 NORTH AMERICA MEDICAL CANNABIS MARKET: COMPANY SHARE 2020 (%) 705
  • FIGURE 80 EUROPE MEDICAL CANNABIS MARKET: COMPANY SHARE 2020 (%) 706
  • FIGURE 81 ASIA-PACIFIC MEDICAL CANNABIS MARKET: COMPANY SHARE 2020 (%) 707